{"id":"https://openalex.org/W2058324429","doi":"https://doi.org/10.1053/shem.2002.35986","title":"Future clinical implications for farnesyltransferase inhibitors in hematologic malignancies","display_name":"Future clinical implications for farnesyltransferase inhibitors in hematologic malignancies","publication_year":2002,"publication_date":"2002-07-01","ids":{"openalex":"https://openalex.org/W2058324429","doi":"https://doi.org/10.1053/shem.2002.35986","mag":"2058324429","pmid":"https://pubmed.ncbi.nlm.nih.gov/12214292"},"language":"en","primary_location":{"id":"doi:10.1053/shem.2002.35986","doi":"https://doi.org/10.1053/shem.2002.35986","is_oa":false,"landing_page_url":"https://doi.org/10.1053/shem.2002.35986","pdf_url":null,"source":{"id":"https://openalex.org/S56632351","display_name":"Seminars in Hematology","issn_l":"0037-1963","issn":["0037-1963","1532-8686"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in Hematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I2801301638","display_name":"Rambam Health Care Campus","ror":"https://ror.org/01fm87m50","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2801301638"]}],"countries":["IL","US"],"is_corresponding":false,"raw_author_name":"Hagop M Kantarjian","raw_affiliation_strings":["Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX 77030, USA","M.D. Anderson Cancer Center, Houston, TX","the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society","institution_ids":["https://openalex.org/I2801301638"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015101485","display_name":"J\u00f6rge E. Cortes","orcid":"https://orcid.org/0000-0002-8636-1071","observed_orcids":["https://orcid.org/0000-0002-8636-1071"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I2801301638","display_name":"Rambam Health Care Campus","ror":"https://ror.org/01fm87m50","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2801301638"]},{"id":"https://openalex.org/I4210162262","display_name":"Blood Cancer United","ror":"https://ror.org/04m0xav37","country_code":"US","type":"other","lineage":["https://openalex.org/I4210162262"]}],"countries":["IL","US"],"is_corresponding":false,"raw_author_name":"Jorge E Cortes","raw_affiliation_strings":["M.D. Anderson Cancer Center, Houston, TX; and the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society","M.D. Anderson Cancer Center, Houston, TX","the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M.D. Anderson Cancer Center, Houston, TX; and the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I2801301638","https://openalex.org/I4210162262"]},{"raw_affiliation_string":"M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society","institution_ids":["https://openalex.org/I2801301638"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068847117","display_name":"Jacob M. Rowe","orcid":"https://orcid.org/0000-0003-0070-8220","observed_orcids":["https://orcid.org/0000-0003-0070-8220"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I2801301638","display_name":"Rambam Health Care Campus","ror":"https://ror.org/01fm87m50","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2801301638"]},{"id":"https://openalex.org/I4210162262","display_name":"Blood Cancer United","ror":"https://ror.org/04m0xav37","country_code":"US","type":"other","lineage":["https://openalex.org/I4210162262"]}],"countries":["IL","US"],"is_corresponding":false,"raw_author_name":"Jacob M Rowe","raw_affiliation_strings":["M.D. Anderson Cancer Center, Houston, TX; and the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society","M.D. Anderson Cancer Center, Houston, TX","the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M.D. Anderson Cancer Center, Houston, TX; and the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I2801301638","https://openalex.org/I4210162262"]},{"raw_affiliation_string":"M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society","institution_ids":["https://openalex.org/I2801301638"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I2801301638","display_name":"Rambam Health Care Campus","ror":"https://ror.org/01fm87m50","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2801301638"]},{"id":"https://openalex.org/I4210162262","display_name":"Blood Cancer United","ror":"https://ror.org/04m0xav37","country_code":"US","type":"other","lineage":["https://openalex.org/I4210162262"]}],"countries":["IL","US"],"is_corresponding":true,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":["M.D. Anderson Cancer Center, Houston, TX; and the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society","M.D. Anderson Cancer Center, Houston, TX","the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M.D. Anderson Cancer Center, Houston, TX; and the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I2801301638","https://openalex.org/I4210162262"]},{"raw_affiliation_string":"M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"the Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel. Dr Cortes is a Clinical Research Scholar for the Leukemia and Lymphoma Society","institution_ids":["https://openalex.org/I2801301638"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5053481267"],"corresponding_institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I2801301638","https://openalex.org/I4210162262"],"apc_list":{"value":4070,"currency":"USD","value_usd":4070},"apc_paid":null,"fwci":0.4603,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.64628992,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"3","first_page":"36","last_page":"38"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0689999982714653,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/farnesyltransferase-inhibitors","display_name":"farnesyltransferase inhibitors","score":1.0},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.9850000143051147},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.972000002861023},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.6159999966621399},{"id":"https://openalex.org/keywords/molecular-abnormalities","display_name":"molecular abnormalities","score":0.5830000042915344},{"id":"https://openalex.org/keywords/chromosomal-abnormalities","display_name":"chromosomal abnormalities","score":0.8970000147819519},{"id":"https://openalex.org/keywords/unmet-medical-needs","display_name":"unmet medical needs","score":0.48899999260902405},{"id":"https://openalex.org/keywords/clinical-implications","display_name":"clinical implications","score":0.33399999141693115}],"concepts":[{"id":"https://openalex.org/C2778396349","wikidata":"https://www.wikidata.org/wiki/Q410994","display_name":"Farnesyltransferase","level":4,"score":0.8909420371055603},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.6237491369247437},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6027858853340149},{"id":"https://openalex.org/C2908731994","wikidata":"https://www.wikidata.org/wiki/Q2509220","display_name":"Hematologic Neoplasms","level":3,"score":0.5958240032196045},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.5540665984153748},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30136609077453613},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2508257031440735},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2377091646194458},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19609814882278442},{"id":"https://openalex.org/C57790582","wikidata":"https://www.wikidata.org/wiki/Q901141","display_name":"Prenylation","level":3,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019883","descriptor_name":"Alkyl and Aryl Transferases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051231","descriptor_name":"Farnesyltranstransferase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1053/shem.2002.35986","doi":"https://doi.org/10.1053/shem.2002.35986","is_oa":false,"landing_page_url":"https://doi.org/10.1053/shem.2002.35986","pdf_url":null,"source":{"id":"https://openalex.org/S56632351","display_name":"Seminars in Hematology","issn_l":"0037-1963","issn":["0037-1963","1532-8686"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in Hematology","raw_type":"journal-article"},{"id":"pmid:12214292","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12214292","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in hematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3616723749","display_name":null,"funder_award_id":"1R21-CA91518A-1","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8267944203","display_name":"Farnesyltransferase Inhibitor Therapy for Myelodysplasia","funder_award_id":"5r21ca091518-02","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W2085235835","https://openalex.org/W2102901804","https://openalex.org/W2172104048","https://openalex.org/W6685311591"],"related_works":["https://openalex.org/W4239154144","https://openalex.org/W1988763143","https://openalex.org/W2420817029","https://openalex.org/W2059542017","https://openalex.org/W78193929","https://openalex.org/W114846898","https://openalex.org/W2056007788","https://openalex.org/W2102287185","https://openalex.org/W2054459787","https://openalex.org/W2007148967"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}